Hemodynamic goals in randomized clinical trials in patients with sepsis: A systematic review of the literature

Critical Care

Volumn 11, Issue , 2007, Pages

  Sevransky, Jonathan E ^a   Nour, Seema ^b   Susla, Gregory M ^c   Needham, Dale M ^a   Hollenberg, Steven ^d   Pronovost, Peter ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MEDIMMUNE   (United States)

^d Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DOBUTAMINE; HEPARIN; HYDROCORTISONE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CENTRAL VENOUS PRESSURE; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EMBASE; FLUID THERAPY; FOLLOW UP; HEART INDEX; HEART OUTPUT; HEMODYNAMIC MONITORING; HUMAN; INFORMATION RETRIEVAL; MEAN ARTERIAL PRESSURE; MEDLINE; OUTCOMES RESEARCH; OXYGEN THERAPY; PATIENT CARE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; HEMODYNAMICS; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; BLOOD PRESSURE; HEMODYNAMICS; HUMANS; OXYGEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; TREATMENT OUTCOME;

EID: 34547837379     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5948     Document Type: Review

References (36)

1. Laupland KB Zygun DA Doig CJ Bagshaw SM Svenson LW Fick GH One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system Intensive Care Med 2005 31 2 213-9 10.1007/s00134-004-2544-6 15666140
2. Martin GS Mannino DM Eaton S Moss M The epidemiology of sepsis in the united states from 1979 through 2000 N Engl J Med 2003 348 1546-1554 10.1056/NEJMoa022139 12700374
3. Annane D Aegerter P Jars-Guincestre MC Guidet B for the CUB-Rea Network Current epidemiology of septic shock: The CUB-rea network Am J Respir Crit Care Med 2003 168 165-172 10.1164/rccm.2201087 12851245
4. Dellinger RP Carlet JM Masur H Gerlach H Calandra T Cohen J Gea-Banacloche J Keh D Marshall JC Parker MM for the Surviving Sepsis Campaign Management Guidelines Committee Surviving sepsis campaign guidelines for management of severe sepsis and septic shock Crit Care Med 2004 32 858-873 10.1097/01.CCM.0000117317.18092.E4 15090974
5. Zeni F Freeman B Natanson C Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment Crit Care Med 1997 25 1095-1100 10.1097/ 00003246-199707000-00001 9233726
6. Hollenberg SM For every complex problem, there is a solution that is simple... and wrong Crit Care Med 2000 28 3088-3089 10.1097/ 00003246-200008000-00074 10966306
7. Wheeler AP Bernard GR Treating patients with severe sepsis N Engl J Med 1999 340 207-214 10.1056/NEJM199901213400307 9895401
8. Bone RC Balk RA Cerra FB Dellinger RP Fein AM Knaus WA Schein RM Sibbald WJ Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 1992 101 1644-1655 1303622
9. Jadad AR Moore RA Carroll D Jenkinson C Reynolds DJ Gavaghan DJ McQuay HJ Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996 17 1-12 10.1016/ 0197-2456(95)00134-4 8721797
10. Peake SL Moran JL Leppard PI N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock Crit Care Med 1996 24 1302-1310 10.1097/00003246-199608000-00006 8706483
11. Bollaert PE Charpentier C Levy B Debouverie M Audibert G Larcan A Reversal of late septic shock with supraphysiologic doses of hydrocortisone Crit Care Med 1998 26 645-650 10.1097/ 00003246-199804000-00010 9559600
12. Tuchschmidt J Fried J Astiz M Rackow E Elevation of cardiac output and oxygen delivery improves outcome in septic shock Chest 1992 102 216-220 1623756
13. Cole L Bellomo R Hart G Journois D Davenport P Tipping P Ronco C A phase II randomized, controlled trial of continuous hemofiltration in sepsis Crit Care Med 2002 30 100-106 10.1097/00003246-200201000-00016 11902250
14. Rivers E Nguyen B Havstad S Ressler J Muzzin A Knoblich B Peterson E Tomlanovich M Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 2001 345 1368-1377 10.1056/ NEJMoa010307 11794169
15. Boldt J Papsdorf M Piper SN Rothe A Hempelmann G Continuous heparinization and circulating adhesion molecules in the critically ill Shock 1999 11 13-18 9921711
16. Emet S Memis D Pamukcu Z The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis Crit Care 2004 8 R172-R179 522835 15312215 10.1186/cc2866
17. Briegel J Forst H Hallar M Schelling G Kilger E Kuprat G Hemmer B Hummel T Lenhart A Heyduck M Stoll C Peter K Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single center study Crit Care Med 1999 27 723-732 10.1097/ 00003246-199904000-00025 10321661
18. Alia I Esteban A Gordo F Lorente JA Diaz C Rodriguez JA Frutos F A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock Chest 1999 115 453-461 10.1378/chest.115.2.453 10027447
19. Spapen H Zhang H Demanet C Vleminckx W Vincent JL Huyghens L Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 1998 113 1616-1624 9631802
20. G-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002) Crit Care Med 2004 32 1-12 10.1097/ 01.CCM.0000105118.66983.19 14707554
21. Lopez A Lorente JA Steingrub J Bakker J McLuckie A Willatts S Brockway M Anzueto A Holzapfel L Breen D Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock Crit Care Med 2004 32 21-30 10.1097/01.CCM.0000105581.01815.C6 14707556
22. Hollenberg SM Ahrens TS Annane D Astiz ME Chalfin DB Dasta JF Heard SO Martin C Napolitano LM Susla GM Totaro R Vincent J-L Zanotti-Cavazzoni S Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update Crit Care Med 2004 32 1928-1948 10.1097/ 01.CCM.0000139761.05492.D6 15343024
23. Clark M Plank L Connolly A Streat SJ Hill AA Gupta R Monk DN Shenkin A Hill GL Effect of a chimeric antibody to tumor necrosis factor alpha on cytokine and physiologic responses in patients with severe sepsis. A randomized clinical trial Crit Care Med 1998 26 1650-1659 10.1097/ 00003246-199810000-00016 9781721
24. Kumar A Anel R Bunnell E Zanotti S Habet K Haery C Marshall S Cheang M Neumann A Ali A Kavinsky C Parrillo JE Preload-independent mechanisms contribute to increased stroke volume following large volume saline infusion in normal volunteers: A prospective interventional study Crit Care 2004 8 R128-R136 468893 15153240 10.1186/cc2844
25. Fowler RA Cook DJ The arc of the pulmonary artery catheter JAMA 2003 290 2732-2734 10.1001/jama.290.20.2732 14645317
26. Gattinoni L Brazzi L Pelosi P Latini R Tognoni G Pesenti A Fumagalli R A trial of goal-oriented hemodynamic therapy in critically ill patients N Engl J Med 1995 333 1025-1032 10.1056/NEJM199510193331601 7675044
27. Abraham E Reinhart K Opal S Demeyer I Doig C Rodriguez AL Beale R Svoboda P Laterre PF Simon S Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial JAMA 2003 290 238-247 10.1001/jama.290.2.238 12851279
28. Abraham E Laterre P Garg R Levy H Talwar D Trzaskoma BL Francois B Guy JS Bruckmann M Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death N Engl J Med 2005 353 1332-1341 10.1056/ NEJMoa050935 16192478
29. Warren BL Eid A Singer P Pillay SS Carl P Novak I Chalupa P Atherstone A Penzes I Kubler A High-dose antithrombin III in severe sepsis: A randomized controlled trial JAMA 2001 1869-1878 10.1001/jama.286.15.1869 11597289
30. Abraham E Anzueto A Gutierrez G Tessler S San Pedro G Wunderink R Dal Nogare A Nasraway S Berman S Cooney R Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II study group Lancet 1998 351 929-933 9734938
31. Osman D Ridel C Ray P Monnet X Anguel N Richard C Teboul JL Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge Crit Care Med 2007 35 64-68 10.1097/ 01.CCM.0000249851.94101.4F 17080001
32. Ely EW Baker AM Dunagan DP Burke HL Smith AC Kelly PT Johnson MM Browder RW Bowton DL Haponik EF Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously N Engl J Med 1996 335 1864-1869 10.1056/NEJM199612193352502 8948561
33. Wheeler AP Bernard GR Thompson BT Schoenfeld D Wiedemann HP deBoisblanc B Connors AF Jr Hite RD Harabin AL National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury N Engl J Med 2006 354 2213-2224 10.1056/ NEJMoa061895 16714768
34. Wiedemann HP Wheeler AP Bernard GR Thompson BT Hayden D deBoisblanc B Connors AF Jr Hite RD Harabin AL National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Comparison of two fluid-management strategies in acute lung injury N Engl J Med 2006 354 2564-2575 10.1056/NEJMoa062200 16714767
35. Van den Berghe G Wilmer A Hermans G Meersseman W Wouters PJ Milants I Van Wijngaerden E Bobbaers H Bouillon R Intensive insulin therapy in the medical ICU N Engl J Med 2006 354 449-461 10.1056/NEJMoa052521 16452557
36. Taylor BE Schallom ME Sona CS Buchman TG Boyle WA Mazuski JE Schuerer DE Thomas JM Kaiser C Huey WY Ward MR Efficacy and safety of an insulin infusion protocol in a surgical ICU J Am Coll Surg 2006 202 1-9 10.1016/ j.jamcollsurg.2005.09.015 16377491